Loading...
Influx Healthtech Limited IPO Details – Price, Date, GMP & Analysis
Listed
SME
Price Range:
Rs.96.00
Issue Size:
Rs.58.57 Cr
Lot Size:
1200 shares
Open Date:
June 18
Influx Healthtech Limited IPO Overview
Bidding Dates
June 18 - June 20
Min Investment
₹115,200
Price Range
₹96.00
Issue Size
₹58.57 Cr
IPO DRHP Doc
Company Overview
Influx Healthtech Limited, incorporated in September 2020, specializes in contract manufacturing within the healthcare sector. The company operates three manufacturing facilities in Thane, Maharashtra, and provides end-to-end services for Nutraceutical and Cosmetic firms, including product development, production, and regulatory support. As of June 11, 2025, Influx Healthtech has 163 permanent employees.
IPO Timeline
Opens
Jun 18
Closes
Jun 20
Allotment
Jun 23
Refunds
Jun 24
Shares Credit
Jun 24
Listing
Jun 25
Opens
Jun 18
Closes
Jun 20
Allotment
Jun 23
Refunds
Jun 24
Shares Credit
Jun 24
Listing
Jun 25
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 137.87x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 481.10x | Oversubscribed |
| RII (Retail Individual Investors) | 117.68x | Oversubscribed |
| Total Subscription | 201.35x | Oversubscribed |
Last updated: Jun 20, 2025, 06:22 PM
GMP data will be available when the IPO is actively trading in the grey market.
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | ₹70.3 Cr | ₹41.1 Cr | ₹28.3 Cr |
| Net Worth | ₹36.15 Cr | ₹22.87 Cr | ₹11.65 Cr |
| Profit After Tax | ₹13.37 Cr | ₹11.22 Cr | ₹7.2 Cr |
| Reserves and Surplus | ₹18 Cr | ₹22.85 Cr | ₹11.63 Cr |
| Revenue | ₹104.99 Cr | ₹100.1 Cr | ₹76.07 Cr |
| Total Borrowing | ₹0.22 Cr | ₹0.32 Cr | ₹0.8 Cr |
Financial data is visualized in the chart above
Strengths & Risks Analysis
Key Strengths
Competitive advantages and positive aspects
- Diversified portfolio across nutraceuticals, Ayurveda, and wellness products reduces sector-specific risks.
- Rigorous QA/QC processes, global certifications (ISO, FDA), and adherence to food safety standards ensure consistent high product quality.
- Formulation team develops safe, stable, and custom nutraceutical, cosmetic, and veterinary products for clients.
IPO Details
Influx Healthtech IPO Details
| Face Value | ₹10 per share |
| Fresh Issue (Ex Market Maker) | 46,94,400 shares (aggregating up to ₹45.07 Cr) |
| IPO Date | June 18, 2025 to June 20, 2025 |
| Issue Price | ₹96 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Listing Date | June 25, 2025 |
| Lot Size | 1,200 Shares |
| Net Offered to Public | 57,94,800 shares (aggregating up to ₹55.63 Cr) |
| Offer for Sale (Ex Market Maker) | 11,00,400 shares of ₹10 (aggregating up to ₹10.56 Cr) |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Share Holding Post Issue | 2,31,50,400 shares |
| Share Holding Pre Issue | 1,81,50,000 shares |
| Total Issue Size | 61,00,800 shares (aggregating up to ₹58.57 Cr) |
Influx Healthtech IPO Reservation
Share Reservation Distribution
QIB
2,895,600 shares (45.2%)
Retail
2,029,200 shares (31.67%)
Anchor Investors
1,736,400 shares (27.1%)
QIB (Ex-Anchor)
1,159,200 shares (18.09%)
HNI (NII)
870,000 shares (13.58%)
Market Maker
306,000 shares (4.78%)
Influx Healthtech IPO Promoter Holding
| Share Holding Post Issue | 73.53% |
| Share Holding Pre Issue | 99.85% |
Influx Healthtech IPO Listing Details
| ₹96 per share |
| INFLUX |
| June 25, 2025 |
Key Dates
Open Date:June 18
Close Date:June 20
Listing Date:June 25
